Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | MAOA | P21397 | 1/20 | 0.61 |
| ▸ | MAOB | P27338 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | CA12 | O43570 | 6/20 | 0.56 |
| ▸ | CA1 | P00915 | 6/20 | 0.56 |
| ▸ | CA2 | P00918 | 6/20 | 0.56 |
| ▸ | CA9 | Q16790 | 6/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 4/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10431151 | 1.00 | TDP1 (0.71) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL1263135 | 1.00 | TDP1 (0.71) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL7074276 | 1.00 | TDP1 (0.71) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL7081323 | 1.00 | TDP1 (0.71) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL3475950 | 0.98 | TDP1 (0.68) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL166207 | 0.92 | TDP1 (0.65) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL15058382 | 0.91 | TDP1 (0.59) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL136815 | 0.90 | TDP1 (0.85) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL134329 | 0.90 | TDP1 (0.85) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL5162656 | 0.90 | TDP1 (0.85) | TDP1MAOAMAOBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2906659-B1 | REVERSIBLY COAGULATABLE AND REDISPERSABLE POLYMER INCLUDING AT LEAST ONE MONOMER INCLUDING A SWITCHABLE-AMPHIPHILIC FUNCTIONAL GROUP AND METHODS OF USING THE SAME | HALLIBURTON ENERGY SERVICES INC (US) | 2017-08-30 | — | — | EP | disclosed |
| US-9593276-B2 | Reversibly coagulatable and redispersable polymer including at least one monomer including a switchable-amphiphilic functional group and methods of using the same | HALLIBURTON ENERGY SERVICES, INC. (US) | 2017-03-14 | — | — | US | disclosed |
| EP-2906659-A1 | REVERSIBLY COAGULATABLE AND REDISPERSABLE POLYMER INCLUDING AT LEAST ONE MONOMER INCLUDING A SWITCHABLE-AMPHIPHILIC FUNCTIONAL GROUP AND METHODS OF USING THE SAME | Halliburton Energy Services, Inc. (US) | 2015-08-19 | — | — | EP | disclosed |
| US-20140179567-A1 | REVERSIBLY COAGULATABLE AND REDISPERSABLE POLYMER INCLUDING AT LEAST ONE MONOMER INCLUDING A SWITCHABLE-AMPHIPHILIC FUNCTIONAL GROUP AND METHODS OF USING THE SAME | HALLIBURTON ENERGY SERVICES, INC. (US) | 2014-06-26 | — | — | US | disclosed |
| WO-2014099646-A1 | REVERSIBLY COAGULATABLE AND REDISPERSABLE POLYMER INCLUDING AT LEAST ONE MONOMER INCLUDING A SWITCHABLE-AMPHIPHILIC FUNCTIONAL GROUP AND METHODS OF USING THE SAME | HALLIBURTON ENERGY SERVICES, INC. (US) | 2014-06-26 | — | — | WO | disclosed |
| EP-0984936-B1 | CYANOGUANIDINES AS CELL PROLIFERATION INHIBITORS | LEO PHARMA AS WITH SECONDARY N (DK) | 2003-09-03 | — | — | EP | disclosed |